Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa
Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa
Active, not recruiting · NCT07006246 · Registry updated 2025-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 4 | 2025-06-05 | NCT07006246 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bill and Melinda Gates Foundation | 67 |
| Professor Francois Venter | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ezintsha, a division of Wits Health Consortium | Johannesburg | South Africa | 2 |